According to Ligand Pharmaceuticals's latest financial reports the company's total assets are A$1.49 Billion. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | A$1.15 B | 3.1% |
2022-12-31 | A$1.12 B | -37.38% |
2021-12-31 | A$1.78 B | 1.03% |
2020-12-31 | A$1.77 B | -17.02% |
2019-12-31 | A$2.13 B | 19.3% |
2018-12-31 | A$1.78 B | 108.22% |
2017-12-31 | A$0.85 B | 2.99% |
2016-12-31 | A$0.83 B | 20.86% |
2015-12-31 | A$0.69 B | 119.02% |
2014-12-31 | A$0.31 B | 168.57% |
2013-12-31 | A$0.11 B | 17.01% |
2012-12-31 | A$0.10 B | -14.69% |
2011-12-31 | A$0.11 B | 58.1% |
2010-12-31 | A$74.38 M | -52.88% |
2009-12-31 | A$0.15 B | -35.04% |
2008-12-31 | A$0.24 B | 22.61% |
2007-12-31 | A$0.19 B | -52.08% |
2006-12-31 | A$0.41 B | -3.81% |
2005-12-31 | A$0.42 B | 0.08% |
2004-12-31 | A$0.42 B | 1.69% |
2003-12-31 | A$0.42 B | -13.58% |
2002-12-31 | A$0.48 B | 112.38% |
2001-12-31 | A$0.23 B |